Serum alanine aminotransferase flares during interferon treatment of chronic hepatitis B: Is sustained clearance of HBV DNA dependent on levels of pretreatment viremia?

Hepatology

Volumn 34, Issue 5, 2001, Pages 1021-1026

  Nair, Satheesh ^a   Perrillo, Robert P ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; PREDNISONE; RECOMBINANT ALPHA2B INTERFERON; VIRUS DNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CLEARANCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VIREMIA; VIRUS REPLICATION;

EID: 0034761964     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.28459     Document Type: Article

References (16)

1. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B
2. Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B
3. Acute flares in chronic hepatitis B: The natural and unnatural history of an immunologically mediated infection
4. Cytotoxic T cell responses in patients with chronic hepatitis B virus infection undergoing HBe antigen antibody seroconversion
5. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B
6. Treatment of hepatitis B virus infection with interferon. Factors predicting response to interferon
7. Alpha-interferon treatment of chronic hepatitis B infection: Predictors of responsiveness
8. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B
9. A short course of prednisone in chronic type B hepatitis. Report of a randomized, double blind, placebo-controlled trial
10. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial
11. Prednisone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B
12. Prednisoneinterferon combination in the treatment of chronic hepatitis B: Direct and indirect metaanalysis
13. Prednisolone priming enhances Th1 response and efficacy of subsequent lamivudine therapy in patients with chronic hepatitis B
14. Low-dose, titratable interferon alfa in decompensated liver disease caused by chronic infection with hepatitis B virus
15. A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus
16. Therapy for hepatitis B virus infection